Literature DB >> 10886149

Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review.

H Yasuda1, H Kobayashi, T Hashimoto, K Itoh, M Yamane, J Nakamura.   

Abstract

We describe a 40-year-old Japanese man with a 3-year history of vesiculopustular lesions resembling subcorneal pustular dermatosis. Histopathology showed subcorneal pustules containing a few acantholytic cells, and direct immunofluorescence disclosed IgA deposition in the intercellular space of the upper epidermis. Circulating IgA autoantibodies of very low titre were also demonstrated by indirect immunofluorescence. A novel cDNA transfection technique clearly detected IgA autoantibodies reactive with human desmocollin-1. Combined therapy with dapsone and etretinate improved the skin lesions. We review the clinical features of 49 patients in the literature who presented with vesiculopustular lesions and intraepidermal IgA deposition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886149     DOI: 10.1046/j.1365-2133.2000.03604.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  [IgA pemphigus. Successful treatment with mycophenolate mofetil].

Authors:  T Burchardt; A Büchau; T Ruzicka; M Megahed
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

Review 2.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  [IgA pemphigus of the subcorneal pustular dermatosis type. Successful therapy with a combination of dapsone and acitretin].

Authors:  B Monshi; L Richter; T Hashimoto; E Groiß; N Haensch; K Rappersberger
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

4.  Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.

Authors:  Matt Morgan; Andrew Cooke; Laura Rogers; Beverley Adams-Huet; David A Khan
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Sep-Oct

5.  Discrepancies among clinical, histological and immunological findings in IgA pemphigus: a case report and literature survey.

Authors:  Kaja Męcińska-Jundziłł; Takashi Hashimoto; Cezary Kowalewski; Katarzyna Woźniak; Norito Ishii; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

Review 6.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

7.  Pemphigus foliaceus masquerading as IgA pemphigus and responding to dapsone.

Authors:  Manas Chatterjee; Shweta Meru; Biju Vasudevan; Prabal Deb; Nikhil Moorchung
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

Review 8.  Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus.

Authors:  Adriana Maria Porro; Livia de Vasconcelos Nasser Caetano; Laura de Sena Nogueira Maehara; Milvia Maria dos Santos Enokihara
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

9.  Imatinib-induced IgA Pemphigus: Subcorneal Pustular Dermatosis Type.

Authors:  Aradhana Sood; Preema Sinha; Deep K Raman; Anwita Sinha
Journal:  Indian Dermatol Online J       Date:  2018 Sep-Oct

10.  Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases.

Authors:  Xavier Bosch-Amate; Pilar Iranzo; Marta Ivars; José Manuel Mascaró Galy; Agustín España
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.